Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry-Reference-Cited by-同舟云学术

Is Survival for Patients with Resectable Lung Metastatic Colorectal Cancer Comparable to Those with Resectable Liver Disease? Results from the South Australian Metastatic Colorectal Registry

Published:2016-06-01 Issue:11 Volume:23 Page:3616-3622
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

Patel Dainik,Townsend Amanda R.,Karapetis Christos,Beeke Carol,Padbury Rob,Roy Amitesh,Maddern Guy,Roder David,Price Timothy J.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-016-5290-4.pdf

Reference42 articles.

1. Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.

2. Heinemann V, von Weikersthal LF, Decker T, et al. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial. Lancet Oncol. 2014;15(10):1065–75.

3. Venook AP, Niedzwiecki D, Lenz H-J, et al. CALGB/SWOG 80405: phase III trial of irinotecan/5-FU/leucovorin (FOLFIRI) or oxaliplatin/5-FU/leucovorin (mFOLFOX6) with bevacizumab (BV) or cetuximab (CET) for patients (pts) with KRAS wild-type (wt) untreated metastatic adenocarcinoma of the colon or rectum (MCRC). Paper presented at: ASCO Annual Meeting Proceedings 2014.

4. O’Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004;96(19):1420–5.

5. Manfredi S, Bouvier AM, Lepage C, Hatem C, Dancourt V, Faivre J. Incidence and patterns of recurrence after resection for cure of colonic cancer in a well defined population. Br J Surg. 2006;93(9):1115–22.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of an artificial intelligence prediction model and a survival risk stratification for lung metastasis in colorectal cancer from highly imbalanced data: A multicenter retrospective study;European Journal of Surgical Oncology;2023-12

2. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies;Journal of Gastrointestinal Cancer;2023-01-18

3. Treatment intention and outcome in patients with simultaneously diagnosed liver and lung metastases from colorectal cancer;European Journal of Surgical Oncology;2022-08

4. Importance of Local Ablative Therapies for Lung Metastases in Patients With Colorectal Cancer;Annals of Surgery;2022-07-15

5. Survival and prognostic factors of isolated pulmonary metastases originating from colorectal cancer: An 8-year single-center experience;Annals of Medicine & Surgery;2022-05